Here are the treatment news stories with the most views this year:
1. PrEP Fails in Gay Man Adhering to Daily Truvada, He Contracts Drug-Resistant HIV
Posted: February 25
2. What Is Chronic Inflammation and Why Is It Such a Big Deal for People With HIV?
Posted: April 5
3. Second Man Contracts Rare HIV Strain While Adhering to PrEP
Posted: October 19
4. Media Outlets Falsely Claim That a Cure for HIV May Be Only Three Years Away
Posted: April 4
5. Does Undetectable Mean Uninfectious? The Challenge of Explaining HIV Study Results
Posted: July 26
6. New Study Finds HIV Reservoir May Endure Longer Than Previously Thought
Posted: November 23
7. FDA Approves Gilead’s HIV Tablet Odefsey, an Updated Version of Complera
Posted: March 1
8. Is Charlie Sheen Pining After the Wrong Clinical Trial of Long-Acting HIV Meds?
Posted: March 9
9. Researchers Edit HIV Out of Infected Cells
Posted: March 25
10. First U.S. Public Health Official Endorses “Negligible Risk” When Undetectable
Posted: August 12
11. Long-Acting Antibody Successfully Combats Drug-Resistant HIV
Posted: November 17
12. 8-Week Long-Acting Injectable HIV Treatment Succeeds, is Moving to Advanced Trials
Posted: February 26
13. FDA OKs Gilead’s Descovy, a Safer Version of Truvada, for HIV Treatment Only (Not for PrEP)
Posted: April 4
14. Promising Monkey Study Prompts Early Human Trial of HIV Cure
Posted: October 13
15. Gay Men’s HIV Prevalence Varies Widely by City and State, With the South Hit Hard
Posted: May 17
16. HIV Spreads Through the Body Much Faster Than Previously Thought
Posted: April 3
17. HIV Ages Cells by Five Years
Posted: May 4
18. It May Be Possible to Take Atripla Just Three Times a Week
Posted: July 12
19. HIV Antibody 3BNC117 Delays Viral Rebound, Could Be Component of Cure
Posted: June 28
20. Zero HIV Transmissions in Major San Francisco PrEP Program
Posted: August 4
Check out all of our 2016 lists:
Comments
Comments